Gianluca Carlesso is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific binding proteins. With a total of 4 patents to his name, Carlesso's work has the potential to impact therapeutic approaches in medicine.

Latest Patents

One of Carlesso's latest patents focuses on bispecific binding proteins and their uses. The disclosure provides proteins that bind two epitopes, which are bivalent for binding to each of the first and second epitopes. It also includes specific binding proteins, such as antibodies, that target a specific protein. Furthermore, the disclosure outlines compositions comprising these proteins, nucleic acid molecules encoding them, and methods for their production. Importantly, it details methods for inducing an immune response in a subject, as well as strategies for treating or preventing cancer by administering these proteins, nucleic acid molecules, and compositions.

Career Highlights

Gianluca Carlesso is currently associated with MedImmune Limited, where he continues to innovate in the field of biopharmaceuticals. His work is characterized by a commitment to advancing medical science through the development of novel therapeutic agents.

Collaborations

Carlesso has collaborated with esteemed colleagues such as Srinath Kasturirangan and Changshou Gao. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.

Conclusion

Gianluca Carlesso's contributions to the field of biotechnology, particularly through his patents on bispecific binding proteins, highlight his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.